Checked.be
Active
BE 0841.854.288Private limited company
Dr BRAGA S
Manderfeld 97 ·4760 Büllingen, Belgium· 14 yrs active
Sector: General medical practice
(86210)
Conclusion
Dr BRAGA S has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €465k and a net result of €192k. Equity is growing by ~81% per year across the filed fiscal years. Its solvency ranks better than 81% of 1258 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 3 annual accounts.
Key figures
| Equity | €465k |
| Net result | €192k |
| Staff (FTE) | 0.2 |
| Better than sector | 81% |
Financial profile
93
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
88
Profitability
100
Solvency
100
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2011, 14 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
88
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€40k
estimate, not credit advice
Score history
30
2022
96
2023
88
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 10.72 (≥ 1.5)
+10
Quick ratio
Quick ratio 10.72 (≥ 1.0)
+5
Leverage
Debt/equity 0.20 (< 1.0)
+10
Profitability
ROE 41% (≥ 10%)
+10
Interest coverage
Interest coverage 2.0×
+3
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 26-06-2025 with the NBB · fiscal year 2024 · full schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~81%/year over 3 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health activities · compared within the same schema type (full schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 83.2% | 55.2% | |
| Net result | €192k | €71k | |
| Equity | €465k | €317k | |
| Gross operating margin | €144k | €290k | |
| Staff costs | €8k | €170k |
€135k
-55.9%
22-24
€192k
-29.3%
22-24
€213k
-27.3%
22-24
€558k
+27.9%
22-24
€465k
+70.1%
22-24
€445k
+58.7%
22-24
0
0.0%
22-24
€8k
+12.4%
22-24
€20k
-4.8%
22-24
€101k
-
22-24
€94k
-42.7%
22-24
€46k
-39.3%
22-24
€48k
-45.6%
22-24
10.72
+127.3%
22-24
10.72
+127.3%
22-24
83.2%
+33.0%
22-24
0.20
-66.3%
22-24
41.2%
-58.4%
22-24
34.3%
-44.7%
22-24
2.02
-28.4%
22-24
Figures by fiscal year and ratios
| Fiscal year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Deposit | full schema | full schema | full schema |
| Revenue | - | - | - |
| EBITDA | €135k | €306k | €-23k |
| Net profit | €192k | €271k | €-3k |
| Cash flow | €213k | €293k | €19k |
| Staff costs | €8k | €7k | €10k |
| Income taxes | €20k | €21k | €-3k |
| Dividends | - | - | €101k |
| Total assets | €558k | €436k | €371k |
| Equity | €465k | €273k | €22k |
| Debt | €94k | €163k | €348k |
| of which ≤ 1y | €46k | €76k | €221k |
| of which > 1y | €48k | €88k | €127k |
| Working capital | €445k | €281k | €47k |
| Employees (FTE) | 0.2 | 0.2 | 0.3 |
Ratios (computed)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Current ratio | 10.72 | 4.72 | 1.21 |
| Quick ratio | 10.72 | 4.72 | 1.21 |
| Working capital ratio | 79.8% | 64.3% | 12.8% |
| Solvency | 83.2% | 62.6% | 6.0% |
| Debt / equity | 0.20 | 0.60 | 15.66 |
| Long-term debt ratio | 0.10 | 0.32 | 5.73 |
| Interest coverage | 2.02 | 2.82 | -0.27 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | 34.3% | 62.1% | -0.9% |
| ROE | 41.2% | 99.2% | -14.4% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Balance-sheet composition 2024
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €558k | €436k | €371k |
| Fixed assets | 21/28 | €67k | €80k | €102k |
| Tangible fixed assets | 22/27 | €56k | €69k | €91k |
| Financial fixed assets | 28 | €11k | €11k | €11k |
| Current assets | 29/58 | €491k | €356k | €268k |
| Amounts receivable within one year | 40/41 | €80k | €6k | €51k |
| Investments | 50/53 | €325k | - | - |
| Cash & bank | 54/58 | €84k | €348k | €215k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €558k | €436k | €371k |
| Equity | 10/15 | €465k | €273k | €22k |
| Contributions / capital | 10/11 | €12k | €12k | €12k |
| Reserves | 13 | €452k | €261k | €60k |
| Accumulated profits (losses) | 14 | - | - | €-50k |
| Amounts payable | 17/49 | €94k | €163k | €348k |
| Amounts payable after one year | 17 | €48k | €88k | €127k |
| Amounts payable within one year | 42/48 | €46k | €76k | €221k |
| Trade debts payable within one year | 44 | €5k | €8k | €128 |
| Income statement | ||||
| Gross operating margin | 9900 | €144k | €314k | €-12k |
| Operating result | 9901 | €114k | €284k | €-45k |
| Financial income | 75 | €164k | €116k | €124k |
| Financial charges | 65 | €67k | €109k | €85k |
| Result before taxes | 9903 | €211k | €291k | €-7k |
| Income taxes | 67/77 | €20k | €21k | €-3k |
| Net result for the period | 9904 | €192k | €271k | €-3k |
| Result to be appropriated | 9905 | €192k | €271k | €-3k |
Legal Structure
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 08-12-2011 |
| Status | Active |
| Postal code | 4760 |
Establishment units
Dr BRAGA S
since 20122.205.505.232
Updates
2025
26-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Liquidity doublescurrent ratio 10.72
Current ratio from 4.72 to 10.72; short-term debt falls from €76k to €46k.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 61 days late
2023
31-12
Financial
Back to profitnet €271k
Net result €271k after one loss-making year.
31-12
Financial
Liquidity quadruplescurrent ratio 4.72
Current ratio from 1.21 to 4.72; short-term debt falls from €221k to €76k.
31-12
Financial
Equity above €200kEq €273k ▲1127%
Equity rises from €22k to €273k.
20-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 22 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
2020
14-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 14 days late
2019
27-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 58 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 31 days late
2017
28-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 28 days late
2016
29-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
General medical practice86210Other professional, scientific and technical activities74909Other professional, scientific and technical activities74999Organisation of conventions and trade shows82300
Names & trade names
| Legal nameFR | Dr BRAGA S |
Similar companies
DOKTER C. SCHELFAUT, ALGEMENE GENEESKUNDE
BE 0627.849.227 · Waasmunster
DR. ABRAMOVA
BE 0843.967.504 · Maasmechelen
Dr C GUYOT - Médecine générale
BE 0843.683.333 · Hotton
Dr. NKOUOKAM Alice
BE 0812.392.024 · La Louvière
CABINET de Médecine Générale Frank Bronckart
BE 0849.170.068 · Ciney